Bildkälla: Stockfoto

Bioservo: Inflection point getting closer - Redeye

Redeye initiates coverage of Bioservo Technologies, a Swedish technology, and medical technology company. Bioservo develops and produces soft exoskeletons for industrial and Life Science use. We see an attractive case with significant upside potential. We now see that the company is approaching an inflection point for long-term growth.

Redeye initiates coverage of Bioservo Technologies, a Swedish technology, and medical technology company. Bioservo develops and produces soft exoskeletons for industrial and Life Science use. We see an attractive case with significant upside potential. We now see that the company is approaching an inflection point for long-term growth.
Börsvärldens nyhetsbrev
ANNONSER